Related Experiment Videos
SONIC HEDGEHOG mutations causing human holoprosencephaly impair neural patterning activity.
Can Schell-Apacik1, Mariel Rivero, Jessica L Knepper
1Division of Human Genetics and Molecular Biology, Department of Pediatrics, The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Holoprosencephaly (HPE) is a brain development disorder linked to mutations in the SHH gene. SHH is important for forming the ventral parts of the brain and spinal cord. This study found that SHH mutations associated with HPE reduce SHH activity in the developing nervous system. These mutations prevent SHH from regulating genes that are normally responsive to SHH signaling. The mutant SHH proteins also show altered immunoreactivity, suggesting changes in their structure. The findings suggest that SHH mutations disrupt neural patterning, leading to HPE. This is the first evidence that SHH mutations impair SHH's function in HPE patients.
Area of Science:
- Neurodevelopmental genetics
- Molecular embryology
- Congenital malformation research
Background:
Holoprosencephaly (HPE) is a developmental disorder affecting forebrain formation. It is linked to ventral neuron loss and is genetically heterogeneous. Multiple genes can cause HPE, but mutations in the SHH gene are most frequently reported. SHH is essential for ventral patterning in the central nervous system. Prior research has shown that SHH signaling regulates gene expression during brain development. However, the functional consequences of SHH mutations in HPE remain unclear. No prior work had resolved how these mutations affect SHH activity in vivo. This gap motivated further investigation into SHH's role in HPE pathogenesis.
Purpose Of The Study:
This study aimed to assess the functional impact of SHH mutations associated with HPE. The authors sought to determine whether these mutations impair SHH activity in the developing nervous system. They focused on two specific SHH mutations identified in HPE patients. The goal was to evaluate how these mutations affect SHH signaling and gene regulation. The study also aimed to examine whether mutant SHH proteins retain normal immunoreactivity. The motivation was to clarify the causal link between SHH mutations and HPE. This approach could help explain how SHH dysfunction leads to ventral patterning defects. The findings could contribute to understanding HPE's molecular basis.
Main Methods:
The researchers used in vivo models to assess SHH activity in developing nervous systems. They introduced SHH mutations known to cause HPE into these models. The study evaluated gene expression patterns regulated by SHH signaling. Immunoreactivity of mutant SHH proteins was analyzed using specific antibodies. The team compared mutant SHH with wild-type SHH in terms of function. They examined whether mutant SHH could induce ventrally expressed genes. The study also assessed conformational changes in mutant SHH proteins. These methods allowed the authors to investigate SHH's patterning role in HPE.
Main Results:
The study found that SHH mutations associated with HPE reduce in vivo SHH activity. These mutations impair SHH's ability to regulate target genes in the developing nervous system. Mutant SHH fails to induce ventrally expressed genes as wild-type SHH does. The mutant proteins show altered immunoreactivity compared to wild-type SHH. This suggests that SHH conformation is disrupted by the mutations. Gene expression patterns normally responsive to SHH are not properly regulated. The findings confirm that SHH mutations affect neural patterning in HPE. This is the first evidence linking SHH mutations to patterning defects in HPE.
Conclusions:
The authors concluded that SHH mutations causing HPE impair SHH's patterning function in the developing nervous system. These mutations disrupt SHH signaling and gene regulation in ventral regions. The altered immunoreactivity of mutant SHH suggests structural changes. The study provides evidence that SHH dysfunction leads to HPE-related neural patterning defects. The findings support the role of SHH in ventral cell induction during brain development. The results are consistent with prior knowledge of SHH's developmental role. The authors propose that these mutations contribute to HPE by disrupting SHH activity. This study advances understanding of HPE's molecular mechanisms.
Frequently Asked Questions
The authors propose that SHH mutations reduce SHH activity in the developing nervous system. This leads to impaired regulation of genes normally responsive to SHH signaling.
The study used in vivo models to evaluate SHH activity and gene expression. Immunoreactivity of mutant SHH proteins was analyzed using specific antibodies.
SHH signaling is required for the normal induction of ventral cell types in the brain and spinal cord. Disruption of this signaling leads to patterning defects seen in HPE.
Altered immunoreactivity suggests that SHH conformation is disrupted by the mutations. This may explain reduced SHH activity in HPE patients.
SHH mutations fail to induce ventrally expressed genes as wild-type SHH does. This disrupts normal gene regulation in the developing nervous system.
The study suggests that SHH mutations cause HPE by impairing SHH's patterning function in the developing nervous system. This provides insight into HPE's molecular basis.